Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
<h4>Background</h4>Recent studies in Mali, Nigeria, and Senegal have indicated that annual (or biannual) ivermectin distribution may lead to local elimination of human onchocerciasis in certain African foci. Modelling-based projections have been used to estimate the required duration of...
Guardado en:
Autores principales: | Hugo C Turner, Thomas S Churcher, Martin Walker, Mike Y Osei-Atweneboana, Roger K Prichard, María-Gloria Basáñez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3071b230cfcd4e00a4ebffa8a627303a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
por: Natalie V S Vinkeles Melchers, et al.
Publicado: (2021) -
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
por: Elizabeth A Cromwell, et al.
Publicado: (2021) -
Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.
por: Sara Lustigman, et al.
Publicado: (2007) -
African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
por: Luc E Coffeng, et al.
Publicado: (2013) -
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Natalie V S Vinkeles Melchers, et al.
Publicado: (2021)